Dr. Carla J. Sand, MD

Dr. Sand practices at Crownpoint Health Care Facility in Crownpoint, New Mexico, part of U.S. Department of Health and Human Services.

Dr. Sand's NPI, 1639183122, was assigned on July 28, 2006. Dr. Sand graduated from University of New Mexico School of Medicine in 2003. Dr. Sand holds New Mexico license MD-2013-0924.

Dr. Sand's primary practice is Crownpoint Health Care Facility, at Junction of Hwy 371, Crownpoint, NM 87313 in Mckinley County. The practice phone is (505) 786-5291. Dr. Sand also practices at Crownpoint Health Care Facility, 343 E Rt 9, Crownpoint, NM 87313.

Dr. Sand's primary practice is Crownpoint Health Care Facility in Crownpoint, New Mexico, part of U.S. Department of Health and Human Services. Dr. Sand is also affiliated with Cibola General Hospital. The medical group on file is Crownpoint Health Care Facility. Dmand AI also links Dr. Sand to 1 more hospital and 2 skilled nursing facilities, each named with a free account. Dr. Sand's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sand practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Sand's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Sand is licensed in New Mexico.

CMS data shows 162 Medicare services from Dr. Sand across 2 procedure codes in 2024, all of them office visits, for 73 Medicare patients. Medicare paid $7,578 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Sand in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 62% have diabetes. 52% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sand's median patient age at 74, with 51% women.

In 2024, Dr. Sand wrote 3,223 Medicare Part D claims for 151 patients. 77% of them were for generic drugs. CMS names the drug for 2,737 of them, across 77 drugs with 11 or more claims each, at $195,009 in total drug cost. In 2023, CMS named 2,429 claims across 70 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sand for performance year 2024, reported as part of a group. Dr. Sand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Sand graduated from University of New Mexico School of Medicine in 2003.